Our dedicated team is on hand to help you maximise your competitive advantage in the markets offering the best opportunities for growth
Emerging markets offer exciting potential. However, these markets are uncertain, less understood and constantly changing. How can global pharma hope to ensure success in these unchartered territories?
Our emerging markets team can help. Over one third of the projects we manage cover one or more of the key countries ear-marked for growth. We carry out large-scale qualitative and quantitative studies across a range of therapy areas, throughout the product lifecycle, in BRIC and beyond.
We know these markets and understand their complexities and characteristics. We apply the same high standards to emerging markets studies as we do all our projects and work with trusted partners on the ground to ensure research is carried out rigorously. Our presentations answer your marketing question, offering clear recommendations for action.
Find out about our expertise in the following regions:
Director Asia Pacific and Emerging Markets
Marc is head of RP's dedicated Emerging Markets division. He has 35 years’ experience of market research, and has specialized in healthcare research since 1996. Marc spent 15 years in Asia, including postings in Shanghai, Hong Kong and Singapore. In 2012 he relocated back to London working closely with pharma companies looking to maximise their ROI in emerging markets. Marc is a regular speaker at industry events and has presented papers on Emerging Markets at EphMRA and PBIRG conferences.